Gender (P = .011) distribution analysis showed a significant deviation between the cancer cases and control cases ( Table 1). The distribution of LAPTM4B genotypes was significantly different between patients and controls. There were more *1/2 and *2/2 genotypes carriers in the case group than control group, while *1/1

carriers were more in the control group ( Table 2). Adjusted by gender, unconditional logistic regression analyzes showed that subjects with LAPTM4B *1/2 and LAPTM4B *2/2 had a 1396-fold (95% CI = 1.011-1.926) and 1.619-fold (95% CI = 0.868-3.020 higher risk for developing melanoma compared with *1/1 carrier. The allele frequency was also check details noticed between patients and healthy controls (Table 2). In 617 controls, the LAPTM4B*2 allele frequency was 25.6%, which is significantly lower than that in the cases (30.9%). Subjects carrying LAPTM4B*2 have a 1.038-fold higher risk compared with LAPTM4B*1 carriers (95% CI = 1.028-1.663). mTOR inhibitor The association between LAPTM4B genotypes and various clinicopathological features in cases were analyzed by χ2 test ( Table 2). There was no association between LAPTM4B genotypes and gender, age, subtype, Clark level of invasion, Breslow thickness, ulceration, clinical stage, and C-KIT, BRAF gene mutation status. In this study, AM and MM were the most common subtypes accounted for 40% and 26.8% of all cases. Clark level of invasion and Breslow

thickness are melanoma measurement system that related the degree of penetration

of melanoma into the skin to the 5-year survival rate after surgical removal of the melanoma, but they are only suitable for skin original melanoma. Therefore, 26.8% mucosal melanoma origin from gastrointestinal tract, vagina, or choroid and 13.2% primary site unknown cases in this study could not be measured by Clark or Breslow system. Because the site of the primary lesion was obscured, detection of melanoma in China was usually late and 79.5% patients were first diagnosed with lymph node or distant metastasis. Four common genes mutation were also observed in this study. The frequencies of C-KIT gene and BRAF gene mutation were 6.4% (11/171) and 20.5% (35/171) respectively, but NRAS and PDGFR genes mutation were not observed ( Table 3). In this study, we demonstrated that LAPTM4B gene polymorphism is one of the susceptible factors of melanoma occurrence Arachidonate 15-lipoxygenase in Chinese population. Compared with the Western countries, the subtypes of melanoma diagnosed in Chinese patients are different. Previous studies showed that the two most commonly histology subtypes were AM and MM, which accounted for 49.4% and 22.6% [6]. For primary lesions were located in the ultraviolet less contact sites, both the subtypes were not associated with sunlight exposed. The rapid increasing melanoma incidence in China may be associated with the lifestyle changes, although the specific causative factor was still unclear [6].